Danish drugmaker Novo Nordisk said Tuesday it completed its purchase of US-based clinical-stage company Akero Therapeutics. As a result of the closing, Akero's shares will be delisted from the...
Novo Nordisk Concludes Up to $5.2 Billion Takeover of Akero Therapeutics
